Loading bill breakdown…
H.R. 1082119th CongressHealth
Shandra Eisenga Human Cell and Tissue Product Safety Act
Sponsored by Rep. John R. Moolenaar (R-MI) · 1 active : 1 Democrat
Latest action: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Where it standsPassed House, now in the Senate8 senators score as swing votes
Passed House
- House: passedJun 23, 2025
- Senate: next
- President: not yet
Summary
, via Congress.govShandra Eisenga Human Cell and Tissue Product Safety Act
This bill establishes civil penalties for violations of regulations governing the donation and handling of human cell and tissue products. It also requires the Food and Drug Administration (FDA) to report on the regulation of these products and to provide related information to stakeholders. (
Human cell and tissue products
are articles containing or consisting of human cells or tissues that are intended for use in a human recipient.)
Read full summaryHide full summary
Specifically, the bill establishes civil penalties for violations of the FDA’s regulations on donor eligibility and current good tissue practice for manufacturing and distributing human cell and tissue products.
Also, the bill requires the FDA to conduct workshops to educate stakeholders and facilitate discussion on the science and regulation of human cell and tissue products. The FDA must establish a public docket to receive written comments on this topic, and report to Congress with recommendations. The bill also requires the FDA to support the development of educational materials for health care professionals regarding organ, tissue, and eye donations and related topics.
Additionally, the bill requires the FDA to publish on its website educational materials about the Tissue Reference Group (a working group within the FDA) and best practices for obtaining a recommendation from them about human cell and tissue products. Also, annually for three years, the FDA must publish on its website information on inquiries submitted to the Tissue Reference Group and FDA registrations and inspections regarding human cell and tissue manufacturers.
How the projections held up
Each member’s recorded vote compared with their swing projection from before the vote. A member by voting against most of their own party.
House
Passed by voice vote or unanimous consent: no individual votes recorded.
Committees and subjects
Committees
- House Committee on Energy and Commerce · HouseReported by · Markup by · Referred to
- Senate Committee on Health, Education, Labor, and Pensions · SenateReferred to
Subjects
- Administrative law and regulatory procedures
- Civil actions and liability
- Congressional oversight
- Department of Health and Human Services
- Health programs administration and funding
- Health promotion and preventive care
- Organ and tissue donation and transplantation
Model
Directional: count only breaks toward the other partyWhy do scores change?v3default (selected)v2 model swing-v2
How the Senate breaks down
- 8Swing 70–100
- 71Middle 30–70
- 21Entrenched 0–30
Members fall into . All 100 senators have enough data to score.
Key players in the Senate
Ranked by swing score, 0–100 · swing-v3Bars show each input from 0 to 100: ideology gap, scorecard gap, , and the . is the seat’s partisan lean, and shows how much of the input data a score has.
- 1
Susan M. CollinsRepublican · Maine · Lean D+4Senate Committee on Health, Education, Labor, and Pensions
Similar past votes, Senate
Earlier behind swing-v3’s inputLoading similar votes
Cosponsors
1 activeShow all 1 cosponsors
- Debbie Dingell (D-MI-6)
How the swing score works
Ideology gapHow far a member’s DW-NOMINATE voting score sits from their party’s median in the same chamber.
Scorecard gapHow far their Heritage Action and LCV ratings stray from their party’s average, using the groups’ votes on similar bills where available.
Cross-pressureHow strongly their district or state leans toward the other party, from our own computed partisan lean.
Similar votesHow often they voted against their own party on earlier roll calls about this bill or similar ones.
Committee bonusMembers of the committees handling the bill decide whether it moves, so they get a boost.
Cosponsor checkThe sponsor and active cosponsors have already committed, so they drop toward entrenched.
